Organogenesis Holdings Inc. (ORGO) financial statements (2021 and earlier)

Company profile

Business Address 85 DAN ROAD
CANTON, MA 02021
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments84602101
Cash and cash equivalents84602101
Restricted cash and investments000  
Receivables573934  
Inventory, net of allowances, customer advances and progress billings282313  
Inventory282313  
Prepaid expense53200
Total current assets:1741267101
Noncurrent Assets
Property, plant and equipment604740  
Long-term investments and receivables 10  
Due from related parties 10  
Intangible assets, net (including goodwill)594652  
Goodwill292626  
Intangible assets, net (excluding goodwill)312126  
Restricted cash and investments   312310
Deferred income tax assets0 
Other noncurrent assets111  
Other undisclosed noncurrent assets 00  
Total noncurrent assets:1209593312310
TOTAL ASSETS:294221164313311
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities47524540
Accounts payable232819  
Accrued liabilities24232540
Debt17 10  
Restructuring reserve1    
Due to related parties   0 
Business combination, contingent consideration, liability 55  
Other undisclosed current liabilities437 0
Total current liabilities:68606640
Noncurrent Liabilities
Long-term debt and lease obligation535049  
Long-term debt, excluding current maturities535039  
Capital lease obligations10  
Liabilities, other than long-term debt1281  
Deferred rent credit 10
Other liabilities871  
Business combination, contingent consideration, liability4    
Other undisclosed noncurrent liabilities1548 1111
Total noncurrent liabilities:80105501111
Total liabilities:1481651171511
Temporary equity, carrying amount   293295
Stockholders' equity
Stockholders' equity attributable to parent, including:146564755
Common stock000  
Additional paid in capital29922717775
Accumulated deficit(153)(171)(130)(2)(0)
Other undisclosed stockholders' equity attributable to parent   00
Total stockholders' equity:146564755
TOTAL LIABILITIES AND EQUITY:294221164313311

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues338261193  
Cost of revenue(87)(76)(69)  
Gross profit:251185125  
Operating expenses(224)(214)(176)(5)(0)
Operating income (loss):27(29)(52)(5)(0)
Nonoperating income (expense)(9)(11)(13)2 
Investment income, nonoperating  02 
Interest and debt expense(11)(2)(2)  
Income (loss) from continuing operations before equity method investments, income taxes:7(42)(67)(2)(0)
Other undisclosed income from continuing operations before income taxes1122  
Income (loss) from continuing operations before income taxes:18(40)(65)(2)(0)
Income tax expense(1)(0)(0)  
Net income (loss) attributable to parent:18(40)(65)(2)(0)
Other undisclosed net loss available to common stockholders, basic (1) (2) 
Net income (loss) available to common stockholders, diluted:18(41)(65)(4)(0)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):18(40)(65)(2)(0)
Comprehensive income (loss), net of tax, attributable to parent:18(40)(65)(2)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: